for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ContraFect Corp

CFRX.OQ

Latest Trade

0.34USD

Change

0.02(+5.41%)

Volume

463,972

Today's Range

0.31

 - 

0.35

52 Week Range

0.27

 - 

2.60

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Contrafect Reports Q3 Loss Per Share Of $0.07

Nov 12 (Reuters) - ContraFect Corp <CFRX.O>::CONTRAFECT REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q3 LOSS PER SHARE $0.07.Q3 EARNINGS PER SHARE ESTIMATE $-0.07 -- REFINITIV IBES DATA.CONTRAFECT - AS OF SEPTEMBER 30, CO HAD CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES OF $10.5 MILLION.

Contrafect Q2 Loss Per Share $0.11

ContraFect Corp <CFRX.O>::CONTRAFECT REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q2 LOSS PER SHARE $0.11.Q2 EARNINGS PER SHARE ESTIMATE $-0.09 -- REFINITIV IBES DATA.AS OF JUNE 30, 2019, CONTRAFECT HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $14.2 MILLION VERSUS $30.5 MILLION AT DECEMBER 31, 2018.

Contrafect Reports Q1 Earnings Per Share Of $0.15

May 10 (Reuters) - ContraFect Corp <CFRX.O>::CONTRAFECT REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q1 EARNINGS PER SHARE $0.15.Q1 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.

Contrafect Announces CEO Transition

April 2 (Reuters) - ContraFect Corp <CFRX.O>::CONTRAFECT ANNOUNCES CEO TRANSITION.CONTRAFECT CORP - ROGER J. POMERANTZ WILL SUCCEED STEVEN C. GILMAN, PH.D., WHO IS RETIRING FROM HIS POSITION AS CHAIRMAN AND CEO..CONTRAFECT CORP - ROGER J. POMERANTZ HAS BEEN APPOINTED CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF CONTRAFECT.CONTRAFECT CORP - POMERANTZ WAS MOST RECENTLY CHAIRMAN AND CEO OF SERES THERAPEUTICS.

ContraFect Reports Q4 EPS Of $0.07

March 14 (Reuters) - ContraFect Corp <CFRX.O>::CONTRAFECT REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q4 EARNINGS PER SHARE $0.07.Q4 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.AS OF DECEMBER 31, 2018, HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $30.5 MILLION.

Antimicrobials Working Group Announces Updates To Leadership Team

Jan 17 (Reuters) - Antimicrobials Working Group::ANTIMICROBIALS WORKING GROUP ANNOUNCES UPDATES TO LEADERSHIP TEAM.ANTIMICROBIALS WORKING GROUP - APPOINTMENT OF NEW CHAIRMAN, EVAN LOH.ANTIMICROBIALS WORKING GROUP - LOH REPLACES JEFFREY STEIN.

ContraFect's Exebacase Improved Clinical Outcomes In Phase 2 Study Compared To Standard Of Care Antibiotics

Jan 7 (Reuters) - ContraFect Corp <CFRX.O>::CONTRAFECT’S EXEBACASE (CF-301) IMPROVED CLINICAL OUTCOMES IN STAPHYLOCOCCUS AUREUS BACTEREMIA INCLUDING RIGHT-SIDED ENDOCARDITIS COMPARED TO STANDARD OF CARE ANTIBIOTICS ALONE IN A FIRST-IN-PATIENT PHASE 2 SUPERIORITY STUDY.CONTRAFECT CORP - COMPANY INTENDS TO PROGRESS EXEBACASE TO PHASE 3.CONTRAFECT CORP - EXEBACASE DEMONSTRATED ROBUST SAFETY AND TOLERABILITY PROFILE.CONTRAFECT CORP - AMONG ALL PATIENTS WHO RECEIVED STUDY DRUG, 19.4% OF EXEBACASE PATIENTS AND 14.9% OF PLACEBO PATIENTS DIED.CONTRAFECT - THERE WERE NO SERIOUS TREATMENT EMERGENT ADVERSE EVENTS THAT CO DETERMINED TO BE RELATED TO EXEBACASE.CONTRAFECT CORP - ANNOUNCED POSITIVE TOPLINE RESULTS FROM ITS PHASE 2 CLINICAL TRIAL OF EXEBACASE.

ContraFect Corp Files For $100 Mln Mixed Shelf Offering-SEC Filing

Nov 30 (Reuters) - ContraFect Corp <CFRX.O>::CONTRAFECT CORP FILES FOR $100 MILLION MIXED SHELF OFFERING - SEC FILING.

Contrafect Q3 Loss Per Share $0.06

Nov 8 (Reuters) - ContraFect Corp <CFRX.O>::CONTRAFECT ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.06.Q3 EARNINGS PER SHARE VIEW $-0.10 -- THOMSON REUTERS I/B/E/S.

Contrafect Q2 Loss Per Share $0.27

ContraFect Corp <CFRX.O>::CONTRAFECT ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.27.Q2 EARNINGS PER SHARE VIEW $-0.10 -- THOMSON REUTERS I/B/E/S.AS OF JUNE 30, 2018, CONTRAFECT HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $33.3 MILLION.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up